Csenge Advisory Group - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.

Quarter-by-quarter ownership
Csenge Advisory Group ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$430,210
+75.0%
15,987
+95.8%
0.03%
+81.2%
Q2 2023$245,818
-27.9%
8,164
-8.2%
0.02%
-40.7%
Q1 2022$341,000
+711.9%
8,895
+294.6%
0.03%
+68.8%
Q3 2018$42,000
-88.8%
2,254
-86.6%
0.02%
-88.3%
Q2 2018$374,000
+50.8%
16,772
+48.9%
0.14%
+59.3%
Q1 2018$248,000
-99.9%
11,262
+13.1%
0.09%
-4.4%
Q3 2017$228,544,0009,9540.09%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders